Literature DB >> 8044822

Tumor-infiltrating lymphocytes: their phenotype, functions and clinical use.

T L Whiteside1, G Parmiani.   

Abstract

Mesh：

Year:  1994        PMID： 8044822     DOI： 10.1007/bf01517175

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  69 in total

Review 1.  Tumor-infiltrating lymphocytes as antitumor effector cells.

Authors:  T L Whiteside
Journal:  Biotherapy       Date:  1992

2.  Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.

Authors:  J H Finke; P Rayman; J Alexander; M Edinger; R R Tubbs; R Connelly; E Pontes; R Bukowski
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

3.  Selective usage of TCR V beta in tumor-specific CTL lines isolated from ovarian tumor-associated lymphocytes.

Authors:  C G Ioannides; R S Freedman
Journal:  Anticancer Res       Date:  1991 Sep-Oct       Impact factor: 2.480

Review 4.  Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.

Authors:  K S Ullman; J P Northrop; C L Verweij; G R Crabtree
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

5.  Characterization of T-lymphocyte subpopulations infiltrating primary breast cancer.

Authors:  R Bilik; C Mor; B Hazaz; C Moroz
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 6.  Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?

Authors:  G Parmiani; A Anichini; G Fossati
Journal:  J Natl Cancer Inst       Date:  1990-03-07       Impact factor: 13.506

Review 7.  Tumor antigens recognized by cytolytic T lymphocytes: present perspectives for specific immunotherapy.

Authors:  T Boon
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

8.  Clonal analysis of tumor-infiltrating lymphocytes from human primary and metastatic liver tumors.

Authors:  Y Shimizu; S Iwatsuki; R B Herberman; T L Whiteside
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

9.  Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes: modulation of recognition through retroviral transduction of tumor cells with interleukin 2 complementary DNA and exogenous alpha interferon treatment.

Authors:  D J Schendel; B Gansbacher
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

10.  Analysis of T cell receptor beta and gamma genes from peripheral blood, regional lymph node and tumor-infiltrating lymphocyte clones from melanoma patients.

Authors:  M R Albertini; J A Nicklas; B F Chastenay; T C Hunter; R J Albertini; S S Clark; J A Hank; P M Sondel
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968
View more
  13 in total

1.  Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.

Authors:  Ngozi Monu; Alan B Frey
Journal:  Cancer Res       Date:  2007-12-01       Impact factor: 12.701

2.  Cutting edge: delay and reversal of T cell tolerance by intratumoral injection of antigen-loaded dendritic cells in an autochthonous tumor model.

Authors:  Eileen M Higham; Ching-Hung Shen; K Dane Wittrup; Jianzhu Chen
Journal:  J Immunol       Date:  2010-04-28       Impact factor: 5.422

3.  A Combination of Systemic and Intracranial Anti-CD25 Immunotherapy Elicits a Long-Time Survival in Murine Model of Glioma.

Authors:  Marie-Denise Poirier; Houda Haban; Abdeljabar El Andaloussi
Journal:  J Oncol       Date:  2010-03-21       Impact factor: 4.375

Review 4.  Signaling defects in anti-tumor T cells.

Authors:  Alan B Frey; Ngozi Monu
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

5.  Culture of tumour-infiltrating lymphocytes from melanoma and colon carcinoma: removal of tumour cells does not affect tumour-specificity.

Authors:  W M Mulder; M J Stukart; M Roos; R A van Lier; J Wagstaff; R J Scheper; E Bloemena
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

6.  Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.

Authors:  Malgorzata Harasymczuk; William Gooding; Aleksandra Kruk-Zagajewska; Jerzy Wojtowicz; Grzegorz Dworacki; Hanna Tomczak; Witold Szyfter; Theresa L Whiteside
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-04       Impact factor: 2.503

7.  Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice.

Authors:  Ailin Bai; Eileen Higham; Herman N Eisen; K Dane Wittrup; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-22       Impact factor: 11.205

8.  Minimal PD-1 expression in mouse and human NK cells under diverse conditions.

Authors:  Sean J Judge; Cordelia Dunai; Ethan G Aguilar; Sarah C Vick; Ian R Sturgill; Lam T Khuat; Kevin M Stoffel; Jonathan Van Dyke; Dan L Longo; Morgan A Darrow; Stephen K Anderson; Bruce R Blazar; Arta M Monjazeb; Jonathan S Serody; Robert J Canter; William J Murphy
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

9.  A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.

Authors:  P Correale; L Micheli; M T Vecchio; M Sabatino; R Petrioli; D Pozzessere; S Marsili; G Giorgi; L Lozzi; P Neri; G Francini
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

Review 10.  Progress and challenges in the vaccine-based treatment of head and neck cancers.

Authors:  Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2009-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.